Skip to content

6348a65d00002622 Ascorbic acid biosynthetic process 1 Mouse

Let me review the model based on what I've found so far:

Review of GO-CAM Model: Ascorbic acid biosynthetic process 1 (Mouse)

Overview

This GO-CAM model (gomodel:6348a65d00002622) represents the ascorbic acid (vitamin C) biosynthetic pathway in mouse, which consists of a sequence of enzymatic activities:

  1. UTP-monosaccharide-1-phosphate uridylyltransferase (Ugp2)
  2. UDP-glucose 6-dehydrogenase (Ugdh)
  3. Alpha-glucuronidase (Ugt1a6a)
  4. L-glucuronate reductase (Akr1a1)
  5. Gluconolactonase (Rgn)
  6. L-gulonolactone oxidase (Gulo)

Strengths of the Model

  1. Accurate Biological Pathway: The model correctly represents the known enzymatic steps in mouse ascorbic acid biosynthesis. This pathway is well-established in the literature.

  2. Correct Causal Flow: The model uses the RO:0002413 "provides input for" relation to connect the enzymes in the proper order of the biochemical pathway, showing a clear linear flow from Ugp2 to Gulo, culminating in the production of L-ascorbate.

  3. Proper Evidence Documentation: Each activity in the model is supported by appropriate evidence codes (ECO terms) and references to scientific literature. The model uses a combination of direct assay (ECO:0000314), mutant phenotype (ECO:0000315), genetic interaction (ECO:0000316), and sequence orthology (ECO:0000266) evidence.

  4. Taxonomic Specificity: The model is correctly specified as being for mouse (NCBITaxon:10090), which is appropriate since mice, unlike humans, can synthesize ascorbic acid.

Areas for Improvement or Verification

  1. Molecular Input/Output Specification: While L-ascorbate is specified as the output of the Gulo activity, intermediate metabolites between the other enzymatic steps are not explicitly represented as inputs/outputs. Adding these would enhance the clarity of the model.

  2. Part_of Relation Consistency: All activities are annotated as part_of GO:0009058 (biosynthetic process), which is correct but somewhat general. It would be more specific to annotate them as part_of "ascorbic acid biosynthetic process" (GO:0019853).

  3. Missing Subcellular Location: The model doesn't specify the subcellular locations of these activities. Based on the UniProt data, these enzymes function in different cellular compartments (e.g., cytoplasm, endoplasmic reticulum).

  4. Evidence Documentation: Although evidence is present, some activities rely on a single piece of evidence. Additional supporting evidence would strengthen the model.

  5. Missing Context: It would be useful to include information about tissue-specificity (liver is the primary site of ascorbic acid synthesis in mice).

Recommendations

  1. Add Intermediate Metabolites: Specify the chemical entities that serve as inputs and outputs for each enzymatic step:

  2. Beta-D-glucose 1-phosphate → UDP-glucose → UDP-glucuronate → L-gluconate → L-gulonolactone → L-ascorbate

  3. Refine Part_of Relations: Consider changing the part_of relationship from the general "biosynthetic process" to the more specific "ascorbic acid biosynthetic process" (GO:0019853).

  4. Add Subcellular Locations: Add cellular component annotations for each activity, particularly for Gulo which is known to be localized to the endoplasmic reticulum.

  5. Context Enrichment: Consider adding information about the tissue context (liver) where this pathway primarily occurs.

  6. Activity Regulation: Based on the literature (like PMID:10606751), there's evidence that this pathway is regulated by the aromatic hydrocarbon receptor (AhR). This regulatory aspect could be incorporated into the model.

Conclusion

Overall, this GO-CAM model accurately represents the ascorbic acid biosynthetic pathway in mouse with appropriate causal connections between activities. The model follows GO-CAM best practices in terms of using appropriate evidence codes and references. With the suggested enhancements, the model could provide an even more comprehensive representation of this important biosynthetic pathway.